Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A critical re-evaluation of the regression model specification in the US D1 EQ-5D value function.
Rand-Hendriksen K, Augestad LA, Dahl FA.
Popul Health Metr. 2012 Jan 13;10(1):2.
Related citations
US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
Shaw JW, Johnson JA, Coons SJ.
Med Care. 2005 Mar;43(3):203-20.
A median model for predicting United States population-based EQ-5D health state preferences.
Shaw JW, Pickard AS, Yu S, Chen S, Iannacchione VG, Johnson JA, Coons SJ.
Value Health. 2010 Mar-Apr;13(2):278-88. Epub 2009 Dec 4.
[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].
Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ.
Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8. Dutch.
A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions.
Nan Luo, Johnson JA, Shaw JW, Coons SJ.
Med Decis Making. 2007 May-Jun;27(3):321-6.
The social tariff of EQ-5D is not adequate to assess quality of life in patients with low back pain.
Zamora J, Kovacs F, Abraira V, Fernández C, Lázaro P; Spanish Back Pain Research Network.
Qual Life Res. 2007 Apr;16(3):523-31. Epub 2006 Nov 17.
Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods.
Craig BM, Busschbach JJ, Salomon JA.
Med Care. 2009 Jun;47(6):634-41.
Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.
Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R.
Med Decis Making. 2010 May-Jun;30(3):341-54. Epub 2009 Oct 26.
Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).
Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A.
Br J Rheumatol. 1997 May;36(5):551-9.
Modelling valuations for Eq-5d health states: an alternative model using differences in valuations.
Dolan P, Roberts J.
Med Care. 2002 May;40(5):442-6.
The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets.
Lamers LM.
Med Care. 2007 Mar;45(3):238-44.
Social valuation of EQ-5D health states: the Chilean case.
Zarate V, Kind P, Valenzuela P, Vignau A, Olivares-Tirado P, Munoz A.
Value Health. 2011 Dec;14(8):1135-41. Epub 2011 Nov 6.
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
Kharroubi SA, O'Hagan A, Brazier JE.
Stat Med. 2010 Jul 10;29(15):1622-34.
Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
Zarate V, Kind P, Chuang LH.
Value Health. 2008 Dec;11(7):1170-7. Epub 2008 May 16.
A Shortcut to Mean-Based Time Tradeoff Tariffs for the EQ-5D?
Rand-Hendriksen K, Augestad LA, Dahl FA, Kristiansen IS, Stavem K.
Med Decis Making. 2012 Jan 12. [Epub ahead of print]
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
To what extent do people prefer health states with higher values? A note on evidence from the EQ-5D valuation set.
Roberts J, Dolan P.
Health Econ. 2004 Jul;13(7):733-7.
Inconsistencies in TTO and VAS values for EQ-5D health states.
Lamers LM, Stalmeier PF, Krabbe PF, Busschbach JJ.
Med Decis Making. 2006 Mar-Apr;26(2):173-81.
The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
Russell RT, Feurer ID, Wisawatapnimit P, Pinson CW.
Liver Transpl. 2009 Jan;15(1):88-95.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on